Exact Sciences (EXAS) Tops Q3 EPS by 23c
Tweet
Share
E-mail
Get Alerts EXAS Hot Sheet
Price: $104.91 --0%
Financial Fact:
Loss from operations: -38.28M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Financial Fact:
Loss from operations: -38.28M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Exact Sciences (NASDAQ: EXAS) reported Q3 EPS of ($0.84), $0.23 better than the analyst estimate of ($1.07). Revenue for the quarter came in at $523.1 million versus the consensus estimate of $503.13 million.
GUIDANCE:
Exact Sciences sees FY2022 revenue of $2.025-2.042 billion, versus the consensus of $2.01 billion.
For earnings history and earnings-related data on Exact Sciences (EXAS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Ridgepost Capital acquires Stellus Capital Management for $4B AUM
- AXT appoints Tracy Liu to its board of directors
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
